Risk of New Bloodstream Infections and Mortality Among People Who Inject Drugs With Infective Endocarditis

In this study, new BSIs were common in PWID receiving parenteral treatment for infective endocarditis. Discharging patients to outpatient treatment was not associated with an increase in new BSI incidence or mortality; carefully selected PWID may therefore be considered for such treatment.